InvestorsHub Logo
Followers 116
Posts 1877
Boards Moderated 0
Alias Born 11/22/2017

Re: A deleted message

Monday, 08/03/2020 5:12:39 PM

Monday, August 03, 2020 5:12:39 PM

Post# of 701760

Then in Dec 2014 LP said there would be an efficacy IA in H1 2015.



Ex,

April 9, 2015.

Anticipated Milestones and Catalysts in 2015.

DCVax-L Phase III Trial Program
*
* First interim analysis for efficacy – independent DMC review



April 9, 2015 – Leslie J. Goldman, Senior Vice President Business Development, presents at the World Vaccine Congress 2015.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News